Previous research has identified (1) a "deficit" subtype of schizophrenia characterized by enduring negative symptoms and diminished emotionality and (2) a "distress" subtype associated with high emotionality-including anxiety, depression, and stress sensitivity. Individuals in deficit and distress categories differ sharply in development, clinical course and behavior, and show distinct biological markers, perhaps signaling different etiologies. We tested whether deficit and distress subtypes would emerge from a simple but novel data-driven subgrouping analysis, based on Positive and Negative Syndrome Scale (PANSS) negative and distress symptom dimensions, and whether subgrouping was informative regarding other facets of behavior and brain function. PANSS data, and other assessments, were available for 549 people with schizophrenia diagnoses. Negative and distress symptom composite scores were used as indicators in 2-step cluster analyses, which divided the sample into low symptom (n = 301), distress (n = 121), and deficit (n = 127) subgroups. Relative to the low-symptom group, the deficit and distress subgroups had comparably higher total PANSS symptoms (Ps < .001) and were similarly functionally impaired (eg, global functioning [GAF] Ps < .001), but showed markedly different patterns on symptom, cognitive and personality variables, among others. Initial analyses of functional magnetic resonance imaging (fMRI) data from a 182-participant subset of the full sample also suggested distinct patterns of neural recruitment during working memory. The field seeks more neurosciencebased systems for classifying psychiatric conditions, but these are inescapably behavioral disorders. More effective parsing of clinical and behavioral traits could identify homogeneous target groups for further neural system and molecular studies, helping to integrate clinical and neuroscience approaches.
Introduction
Researchers are actively seeking clinical and pathophysiological markers of specific facets of psychiatric disorder to divide heterogeneous diagnostic categories into more objectively classified, treatment-relevant subgroups. [1] [2] [3] Data-driven subgrouping analyses offer one approach. [4] [5] [6] Recent analyses have pursued this strategy in samples that cross psychotic disorder diagnoses. 7, 8 In one large cohort, relying only on a neuropsychological composite variable and a "sensorimotor reactivity" variable derived from EEG and ERP indexes, Clementz et al. 7 identified 3 subgroups or "biotypes" of psychotic illness. The largest subgroup was comparable to controls in cognitive performance and reactivity; another subgroup showed severe cognitive impairment and low reactivity, "prototypical of chronic, deteriorated, poor-outcome" psychosis (p.381); and the third showed intermediate cognitive impairment and extremely high electrophysiological reactivity. 7 These subgroups differed more clearly than broad DSM diagnostic groups on variables external to the clustering (eg, grey matter), perhaps pointing toward a "more neuroscience-based classification of the psychoses" (p.373). However, the authors noted a need for more clinically feasible means of identifying subgroups. 7 Well-established lines of symptom-based research in the schizophrenia spectrum disorders may help to integrate clinical and neuroscience approaches to heterogeneity reduction. There is considerable evidence that between 15% and 30% of individuals with schizophrenia have "a separate disease within the syndrome of schizophrenia" characterized by primary and enduring negative symptoms with diminished levels of emotionality or distress ("deficit"). [10] [11] [12] [13] [14] [15] This "deficit" group is associated with male sex, poor premorbid course, impaired cognitive performance, reduced insight, disorganized symptoms, and social withdrawal. [16] [17] [18] [19] [20] [21] Other evidence suggests neuroimaging differences in deficit individuals, 22, 23 heritability of the deficit subtype, 24, 25 and linkage to specific genetic loci. 26, 27 Separate work indicates that psychological and biological traits particularly associated with high emotionality and distress ("distress")-neuroticism, anxiety and depression, stress sensitivity, cortisol levels-are linked with positive and affective symptom configurations in schizophrenia [28] [29] [30] [31] [32] [33] [34] [35] but not with negative or deficit symptom configurations. 28, 30, 33, 36 Relationships among psychotic and dysphoric traits and disorders are complex and reciprocal, 32, 35, 37, 38 and comorbidity is common. 37, 39, 40 Indeed, findings establishing that distress-related personality traits (eg, neuroticism) and biological markers (eg, cortisol) are risk factors for the development of schizophrenia and other psychotic disorders, [41] [42] [43] [44] [45] [46] have led van Os and others to argue that there is an "affective pathway to psychosis." 47 This high distress form of schizophrenia is characterized by more acute onset and episodic course, larger numbers of female and schizoaffective cases, positive and affective symptoms, and less severe cognitive impairment. 34, 35, 47 Associations have also been found between distress and poor treatment compliance, low quality of life, increased smoking, higher suicide risk, and poor social role functioning. 31, 37, 38, 48, 49 Specific biological associations of distress characteristics in schizophrenia with white matter integrity, 35 cortisol, 29, 46 stress-induced kynurenic acid levels, 50 and inflammatory cytokines 51 have been reported. It may be possible to distinguish deficit and distress subtypes from one another and from others schizophrenia types based on familiar and readily measurable dimensions of schizophrenia symptomatology. Factor analyses of Positive and Negative Syndrome Scale (PANSS) 52 data consistently identify 5 symptom dimensions, including negative symptom and distress dimensions. 53, 54 The severely elevated negative symptoms (blunted affect, social withdrawal, lack of spontaneity) that are characteristic of deficit schizophrenia are enduring and trait-like. 30, [55] [56] [57] [58] [59] These individuals also show stably "reduced" levels of depression and dysphoria 57, 60, 61 In view of this widely recognized characteristic, the recently developed, consensus Brief Negative Symptom Scale includes a rating of an individual's absence of normal distress as a core negative symptom. 15 A "negative minus distress" symptom formulation, based on PANSS data, has long been used as a proxy to identify deficit schizophrenia. 59 Likewise, distress characteristics tend to be stable in schizophrenia-showing greater consistency over time and across symptomatic and remitted psychotic states than positive and paranoid symptomatology. 30, 56, 58, 62 Thus, PANSS distress symptoms alone (eg, depression, anxiety, guilt, and tension) may offer a further proxy, in this case identifying those whose illness is particularly characterized by distress characteristics. We tested whether deficit and distress subtypes would emerge from a data-driven subgrouping analysis based on PANSS negative and distress symptom dimensions, whether the subgrouping scheme would align with emerging clinical neuroscience (eg, biotypes), and whether it might offer insight into other clinical and functional characteristics, cognition, personality, and brain function.
Methods

Sample
Our sample consisted of 549 individuals between 18 and 60 years of age with DSM-IV schizophrenia disorders, who participated in the NIMH Study of Schizophrenia Genetics between 1999 and 2013. Each subject was diagnosed by a research psychiatrist/clinical psychologist using the Structured Clinical Interview for DSM-IV Axis I Disorders. 63 SCID data and medical records were reviewed in collaboration with a second clinician and a consensus diagnosis was determined based on all available information. Participants were stably treated and gave written informed consent consistent with NIH IRB guidelines. Participants were excluded if they had recent or extended past substance abuse history; serious medical, neurological, or neurodevelopmental conditions; or if estimated IQ was below 70 or there was evidence of a serious learning disability.
Assessment Procedure
Assessment procedures (including neuroimaging) generally were performed on an outpatient basis over 2 days. For ~10% of schizophrenia cases who wished to participate in additional research protocols at NIMH, data sometimes were collected during inpatient stays, although, with few exceptions (<1%), the 2-day assessment protocol was maintained. Participants provided demographic and clinical history information. The PANSS 52 was rated by the same clinicians who performed SCID interviews, and composite scores for negative, positive, concrete/disorganized, distress, and excitability symptoms were derived (see table 1 notes for item assignments) . 53, 54 Data were available from a comprehensive neuropsychological battery. 64 Current analyses examined indexes of general cognitive ability, including estimated IQ and an irregular word-reading test from the Wide Range Achievement Test (WRAT) 65 thought to index pre-diagnosis cognitive ability. We also examined performance on composite variables representing specific cognitive domains that have been shown to be impaired in schizophrenia 64, 66 : verbal memory, processing speed, executive functioning (card sorting), and working memory (span task performance). Regarding dimensions of personality, most participants (n = 399) completed the Tridimensional Personality Questionnaire (TPQ), 67 and Symptom Subgroups in Schizophrenia more recent participants (n = 152) completed the Revised NEO Personality Inventory (NEO). 68 The harm avoidance dimension from the TPQ assesses the stable tendency of an individual to view the world as distressing and threatening. The neuroticism dimension from the NEO is parallel. Although not our main focus in terms of personality, we also explored subgroup differences in TPQ novelty seeking and reward dependence dimensions and in NEO extraversion, openness, agreeableness, and conscientiousness dimensions.
Data Analysis
Our hypothesis was that deficit and distress subtypes of schizophrenia might emerge from data-driven analyses of negative and distress symptom dimensions. To test this, composites representing the 2 PANSS dimensions were analyzed in the full schizophrenia sample using the 2-step clustering procedure in SPSS, version 23 (SPSS: IBM Corp.). 69, 70 We used the stepwise decrease in log-likelihood as the distance measure for identifying clusters and change in the Bayesian Information Criterion to determine the number of clusters to retain. 69, 70 The 2-step procedure performs well with continuously scored variables and is robust to departures from normality. 70, 71 It forms small "preclusters" in an initial step and applies traditional clustering algorithms to the preclusters in a second step. 69, 70 The preclustering step makes the procedure sensitive to order effects. 70 To counter these effects, unsupervised clustering was performed 1000 times, with random re-orderings, to determine the optimal number of clusters. To determine the assignment of individuals to subgroups, we performed an additional 25 analyses, specifying 3 clusters for each solution, again with random re-orderings. Fleiss's kappa 72 was calculated as an index of the extent of agreement in cluster assignment across runs. Receiver operating characteristic (ROC) curve analyses tested whether the pattern of negative and distress composite scores underlying the cluster discrimination conformed to the "negative minus distress" formulation for deficit schizophrenia and the "high distress only" formulation for distress schizophrenia, as hypothesized. General linear model (GLM), logistic regression, and chi-square analyses were used to compare symptom subgroups on demographic, clinical, cognitive and personality variables that were external to the clustering, controlling for age, sex and race. Pairwise analyses used Fisher's LSD procedure, which controls for multiple comparisons among 3 groups. 73 For each subgroup, we conducted discriminant analyses of variables that differed significantly by subgroup, with stepwise entry to highlight the most important discriminating variables.
Imaging
We collected whole brain functional magnetic resonance imaging (fMRI) for a subsample of 182 patients at 3 Tesla (General Electric Sigma Scanners) using gradient-echo echo-planar imaging while subjects performed the N-back working memory paradigm. During the task, the digits 1 through 4 were presented randomly every 2000 ms for a duration of 500 ms at set locations in a diamond-shaped pattern on screen. During the 0-back condition, subjects responded to the current number seen by pressing the appropriate button on a similarly diamond-shaped button box. In the 2-back condition, subjects responded to the number presented 2 digits previously. Four blocks of each condition were presented in 30-second epochs alternating between 0-back and 2-back. Automated algorithms were used to further assess data quality based on signal-to-noise ratio, signal regularity, effects of movement, and other artifacts. After registration to high-resolution anatomical images and smoothing (FWHM 8mm Gaussian filter), data were analyzed with Statistical Parametric Mapping 8 (SPM8) (http://www.fil.ion.ucl.ac.uk/spm, accessed March 6, 2017) using a boxcar convolved with the hemodynamic response function at each voxel. Motion parameters were included as covariates of no interest at the first level.
The N-back paradigm robustly engages a fronto-parietal working memory network, 74 which is abnormal in schizophrenia 75, 76 and sensitive to differing levels of distress. 77 We hypothesized that differences would be evident in frontal, anterior cingulate, and parietal control regions previously associated with working memory performance. 78 We speculated that network activation patterns would be more irregular in more severely affected deficit and distress subgroups. However, in the absence of a framework for predicting regional brain activation differences across these schizophrenia symptom subgroups more specifically, analyses were intended to be hypothesis-generating and exploratory, and they were subjected to rigorous statistical thresholding. We employed an F test in SPM8 with a 3-group contrast to determine regions showing significant variance across groups. We controlled for age, sex, 2-back working memory performance, and race at the second level. From significant maxima identified by the SPM8 F test, we tested for subgroup differences using post hoc t tests in SPM8. 2-back % accuracy differed significantly across subgroups (P < .03) and fMRI findings could reflect these differences. Consequently, we controlled for performance (1) by covarying for 2-back % accuracy in the group of 182 within SPM8, and (2) by analyzing data from smaller groups of 30 patients from each PANSS subgroup matched for 2-back % accuracy (P = .9). The smaller matched subgroups also did not differ in age (P = .18), race (P = .28), or sex (P = .30). Corrected significance levels were determined by permutation testing using 3dClustSim (https://afni.nimh.nih.gov/pub/dist/doc/ program_help/3dClustSim.html, accessed March 6, 2017).
Results
Overall Sample Characteristics
Demographic, diagnostic, clinical, cognitive, and personality traits are summarized in table 1. The sample was heavily Caucasian and male. Individuals were chronic, with moderately severe symptomatology. IQ, education levels, and employment status reflected substantial impairment across participants.
Clustering Based on Negative and Distress Symptom Composites
In 1000 unsupervised clustering runs, 3-cluster solutions (55%) were the most frequent and parsimonious result. The remainder largely comprised 4-(17%) or 5-cluster (23%) solutions. Subgroups from 3-cluster solutions were consistent in terms of size, individual subgroup assignments, and mean indicator values. In 25 further analyses, each constrained to yield a 3-cluster solution, agreement in assignments of individuals to subgroups was high (κ = .867). Table 1 and figure 1a show the distinct patterns of negative and distress symptoms across the 3 subgroups.
Subgroup Comparisons on PANSS Negative and Distress Variables
One subgroup comprised 127 participants with very high negative symptoms and distress symptom levels below the sample average ("deficit subgroup"). ROC curve analysis showed that scores above 14 for the simple "negative minus distress" metric 59 generated a highly congruent deficit subgroup (sensitivity = 0.953, specificity = 0.964, AUC = 0.990, SE = 0.003, P < .0001). A second subgroup of 121 participants was distinguishable from the remaining sample based on the severity of distress symptoms ("distress subgroup"). ROC analysis confirmed that distress composite scores above 8 effectively discriminated this subgroup from the larger sample, again in a manner congruent with the cluster analysis (sensitivity = 0.935, specificity = 0.965, AUC = 0.983, SE = 0.006, P < .0001). The remaining 301 individuals in the sample showed low levels of negative and distress symptoms ("low-symptom subgroup"). For the full sample and within clusters, the negative and distress symptom composite scores were negligibly correlated (ie, rs between .05 in the low-symptom group and .15 in the deficit cluster). Tables 1 and 2 and figures 1b-d show that, while clustering was based only on negative and distress symptoms, the subgroups differed on other PANSS symptom dimensions, and on a wide assortment of other clinical and behavioral indexes. Deficit subgroup members had fewer years of education, were more cognitively impaired at general (IQ and WRAT) and subdomain (eg, processing speed, card sorting) levels, and were more likely than others in the sample to show concrete/disorganized symptomatology. Regarding DSM-IV schizophrenia diagnostic subtypes, the deficit subgroup included higher proportions of undifferentiated and disorganized diagnostic subtypes and a lower proportion of paranoid subtype relative to the overall sample (each χ figure 1b) . Significantly fewer individuals in the deficit subgroup had suicide attempt histories compared to the other subgroups (tables 1 and 2; figure 1c) . Disorganized symptoms and education emerged from discriminant analyses as the most important discriminators of the deficit subgroup from the other subgroups (after negative and distress symptoms). Distress subgroup members showed significantly elevated positive and excitement/hostility symptom levels. This subgroup had the highest average WRAT scores, although performance was intermediate between the lowsymptom and deficit subgroups on other cognitive measures. The distress subgroup differed prominently from the others on the TPQ personality dimension of harm avoidance. In the smaller NEO sample, results for the neuroticism personality dimension were parallel. Post hoc examination of other NEO dimensions indicated reduced extraversion and agreeableness in the high-distress subgroup, as well. In general, the deficit and low-symptom subgroups did not differ on personality variables. While the subgroups did not differ in age at first psychotic episode, the distress group was youngest at the reported onset of prodromal signs (eg, peculiar behavior, withdrawal), although only the difference with the low-symptom group was significant. The distress subgroup also stood out in terms of pharmacological treatment. This subgroup was prescribed the highest level of chlorpromazine equivalents, although the difference was only significant in relation to the low-symptom subgroup. There were no other subgroup differences as to types of antipsychotic treatment (typical, atypical, clozapine) or anticholinergic use. On the other hand, individuals in the distress subgroup were more likely than those in the other subgroups to be treated with mood drugs and sedatives, and were more likely to be taking 3 or more medications (tables 1 and 2, figure 1d ). The distress group also had a higher proportion of the DSM-IV schizoaffective subtypes (each χ 2 [1] > 9.2, each P < .002). TPQ harm avoidance, PANSS excitability/hostility symptoms, and treatment with antidepressants emerged from discriminant analyses as the most important discriminators for this subgroup, beyond the clustering variables.
Subgroup Comparisons on Variables External to the Clustering
The low-symptom group had the lowest levels of overall PANSS symptoms and was low in each symptom dimension. Cognitive impairment was milder in this subgroup than in the deficit subgroup, and dysphoric symptoms and personality traits were low compared to the distress subgroup. This subgroup demonstrated the highest levels of global functioning (GAF) and members were more likely to be working than those in other subgroups. Reversing the pattern seen in the deficit subgroup, the low-symptom group included lower proportions of DSM-IV undifferentiated and disorganized diagnostic subtypes and a higher proportion of paranoid subtype relative to the overall sample (each χ 2 [1] > 8.0, each P < .005). Discriminant analyses highlighted low levels of disorganized symptoms and high GAF as the most important predictors of low-symptom subgroup membership, after negative and distress symptoms.
The foregoing comparisons used subgroup assignments derived from cluster analysis. Results did not differ materially when subgroup assignments were made, instead, on the basis of the "negative minus distress" metric for the deficit subgroup and the "distress only" metric for the distress subgroup, using the cut-off points derived from ROC analyses.
Neuroimaging
Symptom subgroup proportions for the 182 participants with fMRI data closely matched the full sample (tables 1 and 3). Demographics for the subsample were also representative of the full sample, except that average age was 2.4 years lower (P < .002). Across the fMRI subgroups, we found differences in sex (P = .03) and education (P = .01). Differences in symptom dimension composite scores were consistent with findings for the full sample (table 3). As noted above, across the 3 smaller performance-matched cohorts of 30, there were no differences in demographic measures, although expected subgroup differences in symptoms were observed.
The 3-group F test revealed a discontinuous pattern of activation differences across subgroups during working memory performance in dorsolateral prefrontal cortex (dlPFC), parietal cortex, cingulate cortex, and caudate ( figure 2 and table 3 ). Pairwise analyses showed that the low-symptom and high-distress subgroups differed mainly in terms of the degree of activation across the regions (with the high-distress subgroup showing a similar pattern but significantly less activation in each region). However, the deficit subgroup displayed a different profile, marked in particular by greater parietal region activation than seen in the other subgroups. In the smaller matched subgroups, we again identified group differences within right dlPFC (BA 9: MNI x, y, z = 36, 24, 42; F = 4.84, P < .01, P-corrected < .02), closely matching the stronger finding in the full sample (table 3), although the low symptom-todeficit subgroup comparison was less significant, likely due to decreased power (for low symptom > deficit, P = .06; and for low symptom > distress, P = .007). This analysis also revealed an area in left dlPFC (BA 46: MNI −48, 21, 24; F = 6.16, P = .003, P-corrected < .01). The findings in the full imaging subsample using a performance covariate and in the performance-matched subgroups both suggest that the results do not simply reflect task performance. Furthermore, the smaller matched sample results argue against demographic differences as an explanation for our findings in the full fMRI subsample.
Discussion
Clinical experience and prominent, but separate, lines of schizophrenia research indicate that deficit and distress symptom patterns may identify important subgroups of individuals within the heterogeneous schizophrenia diagnostic category. Here we tested whether a simple but novel clustering strategy, using only PANSS negative and distress composite scores, would separate deficit and distress subgroups from others within a large schizophrenia spectrum sample. Based on data from 549 individuals, cluster analyses readily differentiated deficit (23%), distress (22%), and low-symptom (55%) subgroups.
Comparisons of the subgroups on demographic, diagnostic, clinical, cognitive, and personality variables that were not used in the clustering indicated that the 3 subgroups have starkly different characteristics, reaching beyond the 2 symptom dimensions used for clustering. Low-symptom subgroup members had the lowest levels of symptoms and cognitive impairment and the highest levels of GAF, and were more likely to be employed than those in the other subgroups. Deficit subgroup members were more likely than others to be cognitively and educationally impaired and to show symptoms of disorganization, in line with prior findings. 9, 16, 17 Distress subgroup members combined severe distress and positive symptoms 37 with expected elevations in dysphoric personality traits (harm avoidance, neuroticism, low agreeableness), while the deficit subgroup was similar to the low-symptom subgroup on these traits. 30, 34 Perhaps unsurprisingly, distress group members were more likely than others to be prescribed mood medications and sedatives and were more likely to be treated with multiple medications.
Although subgroup assignments were derived empirically through cluster analysis, subsequent ROC analyses showed that the assignments reflected hypothesized symptom patterns. The "negative minus distress" metric previously used to identify deficit schizophrenia, 59 along with the metric cut-off point identified in ROC analyses, yielded a highly congruent deficit subgroup, while the ROC cut-off point for the distress symptom composite alone yielded a closely matching distress subgroup. While further testing and refinement is needed, these findings suggest that a simple clinically-derived subgrouping scheme may complement neuroscience-based approaches to heterogeneity reduction. 7 Exploratory analyses of fMRI data from a 182-participant subset of the full sample identified distinct activation patterns of neural recruitment during working memory that offer hypotheses for future investigation. Subgroup activation differences emerged in primary regions of the fronto-parietal working memory network, 78 including right dlPFC (BA 8/9), left anterior cingulate (BA 32) and left parietal cortex (BA 39/40). The low-symptom subgroup showed significantly greater activation in right dlPFC during working memory performance than the 2 more symptomatic groups, a "healthier" pattern of prefrontal engagement during performance. 79 However, those in the deficit group showed the highest level of parietal cortex activation, perhaps compensatory in nature. 80 Interestingly, the distress subgroup showed the lowest levels of activation across regions, suggesting a broad failure in working memory performance. We have previously commented on the complexity of activation/performance trade-offs and the difficulty of reducing activation pattern differences to simple questions of "too much or too little?" (p. 2209) 75 More detailed understanding of the activation differences observed here may start to emerge from experiments designed a priori to address the symptom subgroups.
Certain findings suggest differences in developmental trajectory among the subgroups. 6, 81 While the clusters did not differ significantly in terms of age at first psychotic episode, higher WRAT reading scores, less impaired general cognitive performance, and greater academic achievement in the distress and low-symptom subgroups compared to the deficit subgroup suggested more benign childhood development for the former subgroups.
However, individuals in our distress subgroup were the youngest, on average, when prodromal symptoms were reported. Various research has emphasized distress characteristics in adolescent/young adult and prodromal individuals (eg, neuroticism, cortisol levels) as risk factors along an "affective pathway to psychosis." 41, [43] [44] [45] [46] Current findings may support a developmental trajectory characterized by precipitous adolescent deterioration for individuals with prominent distress.
The deficit/distress subgrouping scheme captures distinctions in symptoms, cognition and temperament that are relevant clinically and predict differences in the prescription of mood drugs and sedatives. The scheme also might help guide other treatments. 34, 38, 82, 83 For example, the suggestions of Horan et al. 38 -focusing clinical efforts on emotion regulation and stress management interventions for schizophrenia cases experiencing high negative affect (ie, distress), and emphasizing interventions to "increase engagement in pleasurable experiences, mastery experiences, social networks, and physical activity" (p.867) for those with low positive affect (a facet of deficit schizophrenia)-appear directly relevant.
The low-symptom group was larger than the other 2 subgroups combined with relatively milder impairment and better functioning. However, PANSS totals averaging above 46, a cognitive deficit exceeding 1.0 SD, and an employment rate below 40% nevertheless signal substantial impairment. The research strategy we chose focused on deficit and distress symptom patterns. The low-symptom group was defined by the absence of either pattern. We do not propose that this is a homogenous group. It may include individuals whose illness was always mild, individuals who responded well to treatment, and others. Additional investigation, emphasizing different facets of illness and treatment, will be needed to address the heterogeneity within this subgroup.
Deficit schizophrenia generally has been conceptualized as a "true taxon," 10 whereas distress has been viewed more often as a continuous dimensional trait. 38 However, neither of these views is unqualified. The work of van Os and colleagues 47 and others 35 highlights an "affective pathway to psychosis" that might reflect taxon-like etiological distinctions between the distress subgroup and others. Ahmed's recent taxometric analyses of deficit syndrome data concluded that deficit schizophrenia included both dimensional and categorical elements. 10 In the end, we agree with Jablensky's argument 84 that whether a given classification scheme is characterized as discrete, continuous, or hybrid matters less than whether it has predictive power and advances "mechanistic explanation of disease phenomena" (p. 828). Current analyses contribute to this goal.
For example, there are interesting parallels between our findings and those described in Clementz et al., 7 although the studies differed fundamentally in regard to sample composition and the indicators used for clustering. Both analyses yielded 3 subgroups, the largest being a mildly affected, higher functioning subgroup (low-symptom subgroup and biotype 3). Both analyses also yielded a subgroup showing poor functional outcome and significantly impaired cognition (deficit and biotype 1). Significantly, for each of the studies, a third subgroup emerged that was incompatible with a simple severity continuum. 85 In the Clementz et al. results, this group (biotype 2) was characterized by intermediate cognitive impairment, but also by electrophysiological hyper-reactivity. 7 In our analyses, the distress group also showed milder cognitive impairment. At the same time, elevated distress symptoms and neurotic personality traits suggested a kind of behavioral reactivity. Clementz et al. proceeded in a manner agnostic to clinical phenomenology, but it would be of great interest if their neuroscience-based approach pointed back to well-characterized clinical subgroups or dimensions, and if more effective parsing of clinical and behavioral traits, in turn, could identify homogeneous target groups for further neural system and molecular studies. 86 Strengths of the current work include the large sample size and broad clinical and behavioral phenotyping, which allowed multidimensional analysis of variables external to the clustering scheme. 86 However, ours is a convenience sample, comprising mostly chronically ill, medicated individuals and these results may not generalize to all samples. The data were cross-sectional and cannot address the longitudinal stability of the clustering approach. Empirical subgrouping was based on cluster analysis, which has drawn criticism because results may shift on the basis of differences in start values or algorithms. 86 However, we addressed this concern by establishing that similar 3-cluster solutions emerged most frequently in 1000 unsupervised and randomly reconfigured clustering runs, and by showing the high agreement of individual cluster assignments across cluster analysis runs.
Some might view the narrow focus on PANSS negative and distress composites as a limitation. Among other issues, the PANSS negative symptom items do not address anhedonia, and do not adequately capture the distinction between apathy and diminished expression that has emerged in more recent negative symptom research. 15, 87 However, the PANSS continues to be widely used, and these symptom dimensions lie at the intersection of well-developed lines of schizophrenia research: deficit schizophrenia research emphasizing high negative symptoms and low emotionality, and separate research emphasizing high emotionality and dysphoric traits in psychotic disorders. The 2 PANSS composites are independent and longitudinally stable indicators in schizophrenia. 30, 56, 58 Further, these symptom dimensions connect with well-studied aspects of temperament or personality in the general population (eg, negative and positive affect) 38 and with psychopathological processes that cut across psychiatric diagnoses (eg, "anxious misery" and anhedonia). 2, 88, 89 Nevertheless, we recognize that other analytical approaches and other indicators (clinical and biological) may highlight additional important schizophrenia subtypes or dimensions. 87 In conclusion, separate lines of research indicate that "deficit" and "distress" constructs distinguish important subtypes or dimensions of schizophrenia. This study found that these useful distinctions may be made using widely-available PANSS data. The deficit and distress subgroups identified here were similar in terms of overall symptomatology and severity of functional impairment, but they arrived at these outcomes with very different experiences and characteristics, possibly by very different pathophysiological routes. The subgroups were strikingly different-from one another and from the low-symptom subgroup-in patterns of symptoms and clinical markers, personality, brain activation, and cognitive/academic performance, with some evidence of developmental distinctions. These subgroup distinctions may parallel differences identified through neuroscience approaches, 7 and may be useful for clinical planning, as well as for etiological and treatment research. 
